Skip to main content

Table 1 Baseline characteristics of patients treated for in-stent restenosis with paclitaxel-coated angioplasty or drug-eluting stent

From: A retrospective study from a single center to compare outcomes in 79 patients with in-stent restenosis treated with paclitaxel-coated balloon angioplasty or drug-eluting stent implantation

 

PCB % (n = 32)

DES% (n = 51)

p value

Age (years)

57.9 ± 9.5

55 ± 7.3

0.79

Sex, male

65.6% (21)

82.3% (42)

0.13

Diabetes mellitus

37.5% (15)

47.7% (21)

0.18

Hypertension

75% (24)

49% (25)

0.11

Low-density lipoprotein cholesterol level higher than 1.4 mmol/l

25% (8)

35.3% (18)

0.79

Active smoker or stopped for less than 3 years

46.9% (15)

56.8% (29)

0.27

LVEF (%)

55.8% ± 6.8

56.1% ± 8.4

0.88

Personal history of coronary artery disease

25% (8)

45.1% (23)

0.19

  1. PCB Paclitaxel-coated balloon, DES Drug-eluting stent, LVEF Left ventricular ejection fraction